Eton Pharmaceuticals (ETON) Shares Outstanding (Diluted Average) (2020 - 2025)
Eton Pharmaceuticals' (ETON) quarterly Shares Outstanding (Diluted Average) came in at $26.9 million in Q3 2025, up 4.17% year-on-year from $25.8 million in Q3 2024, and up 4.17% quarter-over-quarter from $25.8 million in Q3 2024.
Eton Pharmaceuticals (ETON) Shares Outstanding (Diluted Average) (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $26.9 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 26.89 Mn |
| Sep 30, 2024 | 25.81 Mn |
| Jun 30, 2024 | 25,771.00 |
| Mar 31, 2024 | 25,763.00 |
| Sep 30, 2023 | 25,719.00 |
| Jun 30, 2023 | 25,983.00 |
| Mar 31, 2023 | 25,525.00 |
| Sep 30, 2022 | 25.07 Mn |
| Jun 30, 2022 | 24.92 Mn |
| Mar 31, 2022 | 25.30 Mn |
| Sep 30, 2021 | 25.28 Mn |
| Jun 30, 2021 | 25,211.00 |
| Mar 31, 2021 | 26.55 Mn |
| Jun 30, 2020 | 21.00 Mn |
| Mar 31, 2020 | 18.14 Mn |